Carol Schafer
Board Member
Immunome Inc. (IMNM)Equibles does not estimate personal net worth.
Get an email with a short summary when Immunome Inc. publishes a filing, an earnings call transcript or a press release.
Get IMNM alertsAbout Carol Schafer
Carol Schafer is recorded as Board Member at Immunome Inc. (IMNM) since January 2, 2024. Immunome Inc. reported in an 8-K filed January 2, 2024 that Carol Schafer was appointed Class I director, effective January 2, 2024. Immunome Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunome Inc. includes Clay B. Siegall, Ph.D. (CEO), Clay Siegall (CEO), Corleen Roche (CFO) and 7 others.
“Effective January 2, 2024 (the "Appointment Date"), the Board of Directors (the "Board") of Immunome, Inc. (the "Company"), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Carol Schafer as a Class I director of the Company, with a term of office expiring at the 2024 annual meeting of stockholders.”
Affiliation history
-
Current
2024-01-02–present
Company network
Leadership on record at Immunome Inc.
- Clay B. Siegall, Ph.D. CEO
- Clay Siegall CEO
- Corleen Roche CFO
- Diane Marcou CFO
- Max Rosett CFO
- Matthew K. Robinson CTO
- Sandra Stoneman General Counsel
- Bob Lapetina Chief Accounting Officer
- Franklyn G. Prendergast, M.D., Ph.D. Board Member
- Franklyn Prendergast Board Member